A Phase II Trial of VP-16, Ifosfamide, Cisplatin, Vinblastine, and Bleomycin in Advanced Germ-Cell Tumors
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference8 articles.
1. Treatment of testicular cancer: a new and improved model.
2. Testicular germ cell neoplasms
3. Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.
4. Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
5. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors;Annals of Oncology;2018-02
2. Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014;Annals of Oncology;2016-05
3. RESULT OF TREATMENT FOR ADVANCED GERM CELL TUMOR IN THE LAST DECADE;The Japanese Journal of Urology;2010
4. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs);Cancer Treatment Reviews;2009-11
5. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors;International Journal of Urology;2008-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3